Echo Therapeutics, Inc.
ECTE
Price:
$0.0002
Market Cap:
$0
Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc. to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and oth...[Read more]
Industry
Medical - Devices
IPO Date
2022-01-31
Stock Exchange
OTC
Ticker
ECTE
PE Ratio
[-0.00]
ROE
[-634.55%]
Current Ratio
[0.09]
Dividend Yield
[0%]
Enterprise Value
[273.79K]
Dividend History
The ROE as of December 2025 (TTM) for Echo Therapeutics, Inc. (ECTE) is -634.55%
According to Echo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -634.55%. This represents a change of -2012.76% compared to the average of 33.17% of the last 4 quarters.
Echo Therapeutics, Inc. (ECTE) Historical ROE (quarterly & annually)
How has ECTE ROE performed in the past?
The mean historical ROE of Echo Therapeutics, Inc. over the last ten years is -20.14%. The current -634.55% ROE has changed 3.05% with respect to the historical average. Over the past ten years (40 quarters), ECTE's ROE was at its highest in in the June 2015 quarter at 662.08%. The ROE was at its lowest in in the June 2009 quarter at -166.52%.
Average
-20.14%
Median
-125.95%
Minimum
-160.51%
Maximum
878.82%
Echo Therapeutics, Inc. (ECTE) ROE by Quarter and Year
Discovering the peaks and valleys of Echo Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 160.88%
Maximum Annual ROE = 878.82%
Minimum Annual Increase = -659.27%
Minimum Annual ROE = -160.51%
| Year | ROE | Change |
|---|---|---|
| 2015 | 878.82% | -659.27% |
| 2014 | -157.14% | 59.62% |
| 2013 | -98.44% | -18.33% |
| 2012 | -120.54% | 103.93% |
| 2011 | -59.11% | 24.04% |
| 2010 | -47.65% | -69.42% |
| 2009 | -155.82% | -2.93% |
| 2008 | -160.51% | 22.19% |
| 2007 | -131.36% | -12.23% |
| 2005 | -149.66% | 160.88% |
Echo Therapeutics, Inc. (ECTE) Average ROE
How has ECTE ROE performed in the past?
The current ROE of Echo Therapeutics, Inc. (ECTE) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
207.75%
5-year avg
88.72%
10-year avg
-20.14%
Echo Therapeutics, Inc. (ECTE) ROE vs. Peers
How is ECTE’s ROE compared to its peers?
Echo Therapeutics, Inc.’s ROE is
| Company | ROE | Market cap |
|---|
Build a custom stock screener for Echo Therapeutics, Inc. (ECTE) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Echo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Echo Therapeutics, Inc. (ECTE) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Echo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Echo Therapeutics, Inc.'s ROE?
How is the ROE calculated for Echo Therapeutics, Inc. (ECTE)?
What is the highest ROE for Echo Therapeutics, Inc. (ECTE)?
What is the 3-year average ROE for Echo Therapeutics, Inc. (ECTE)?
What is the 5-year average ROE for Echo Therapeutics, Inc. (ECTE)?
How does the current ROE for Echo Therapeutics, Inc. (ECTE) compare to its historical average?